Myriad Genetics Inc (MYGN)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the data provided, it seems that the days of sales outstanding (DSO) for Myriad Genetics Inc are not available for the years December 31, 2020, 2021, 2022, 2023, and 2024. Without the specific values for DSO, it is challenging to comment on the efficiency of the company in collecting its accounts receivable. DSO is a crucial metric that indicates how long it takes for a company to collect its outstanding receivables, and a lower DSO typically signifies quicker collection and better liquidity.
However, the absence of data for DSO across these years makes it difficult to assess the company's receivables management and overall financial health accurately. It is recommended to monitor this metric in the future to gain insights into the efficiency of Myriad Genetics Inc in collecting payments from customers.
Peer comparison
Dec 31, 2024